Know What's Happening in Industry

Module 2, Section 1: Target Selection Strategy

The module outlines a five‑dimensional framework for target selection, linking biological relevance, drugability, disease impact, competitive landscape, and development risk. It contrasts first‑in‑class and best‑in‑class strategies, highlighting how pioneering mechanisms can command premium market positions. The content identifies oncology as a primary driver of recent innovation, especially through academic‑industry partnerships. Finally, it showcases hyperactivation‑lethality targets such as Daraxonrasib, Lirafugratinib, Bexobrutideg, and Risdipl as exemplars of precision‑oncology pipelines.